SYNTHESIS, BIOLOGICAL EVALUATION AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP ANALYSIS OF NUCLEAR-SUBSTITUTED PARGYLINES AS COMPETITIVE INHIBITORS OF MAO-A AND MAO-B

被引:15
作者
ALI, A [1 ]
ROBINSON, JB [1 ]
机构
[1] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1111/j.2042-7158.1991.tb03476.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of nuclear substituted derivatives of pargyline has been prepared and tested (under controlled conditions designed to measure the competitive component of the inhibition) as competitive inhibitors of MAO-A and -B. Adequate correlation of the biological data with the physicochemical constants of substituent groups was obtained only when the m- and p-substituted derivatives were considered separately. Due to the narrow range of activity displayed by the p-substituted derivates when inhibiting MAO-B, meaningful correlations were not found. However, the inhibition of MAO-B by the m-substituted derivatives required the inclusion of the Verloop L parameter for adequate correlation, suggesting that the inhibitor binding site of MAO-B is present within a cavity of more limited lateral dimensions than that present on the MAO-A surface. Inhibition of both MAO-A and -B demonstrated a parabolic relationship between inhibitory activity and pi. Whereas this parabolic relationship showed a maximal value for inhibition of MAO-A (mean pi(o) = 0.86), inhibition of MAO-B demonstrated a minimal value of pi (pi(min) = -0.5) i.e. the optimal value of pi for inhibition of MAO-B has not been achieved for this series of compounds but such would be greater than that demonstrated for MAO-A. The Hammett sigma-function was important or significant only in the inhibition of MAO-A by the p-substituted derivatives.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 27 条
[1]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[2]   CYANOHYDRIDOBORATE ANION AS A SELECTIVE REDUCING AGENT [J].
BORCH, RF ;
BERNSTEIN, MD ;
DURST, HD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1971, 93 (12) :2897-+
[3]  
Callingham B. A., 1979, MONOAMINE OXIDASE ST, P81
[4]   THE KINETICS OF MONOAMINE-OXIDASE INHIBITION BY 3 2-INDOLYLMETHYLAMINE DERIVATIVES [J].
CRUCES, MA ;
ELORRIAGA, C ;
FERNANDEZALVAREZ, E .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (03) :535-543
[5]   HUMAN-LIVER MAO-A AND MAO-B SEPARATED BY IMMUNOAFFINITY CHROMATOGRAPHY WITH MAO-B-SPECIFIC MONOCLONAL-ANTIBODY [J].
DENNEY, RM ;
FRITZ, RR ;
PATEL, NT ;
ABELL, CW .
SCIENCE, 1982, 215 (4538) :1400-1403
[6]   SYNTHESIS OF CIS- AND TRANS-2-PHENOXYCYCLOPROPYLAMINES AND RELATED COMPOUNDS [J].
FINKELST.J ;
CHIANG, E ;
LEE, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1965, 8 (04) :432-&
[7]   MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].
FOWLER, CJ ;
CALLINGHAM, BA ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101
[8]   THE NATURE OF THE INHIBITION OF RAT-LIVER MONOAMINE-OXIDASE TYPE-A AND TYPE-B BY THE ACETYLENIC INHIBITORS CLORGYLINE, L-DEPRENYL AND PARGYLINE [J].
FOWLER, CJ ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) :3555-3561
[9]   ON THE SUBSTRATE SPECIFICITIES OF 2 FORMS OF MONOAMINE-OXIDASE [J].
FOWLER, CJ ;
TIPTON, KF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (02) :111-115
[10]   STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS [J].
FUJITA, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) :923-930